Predictors of quality of life in patients evaluated for liver transplantation

Clinical Transplantation

Volumn 28, Issue 12, 2014, Pages 1331-1338

  Jara, Maximilian ^a   Bednarsch, Jan ^a   Malinowski, Maciej ^a   Lüttgert, Katja ^a   Orr, James ^b   Puhl, Gero ^a   Seehofer, Daniel ^a   Neuhaus, Peter ^a   Stockmann, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Ascites; Health related quality of life; Hypoproteinemia; Liver transplantation; Quality of life; Transplant candidates

Indexed keywords

CHOLINESTERASE; SERUM ALBUMIN;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; AUTOIMMUNE LIVER DISEASE; BACTERIAL PERITONITIS; BLEEDING; CHILD PUGH SCORE; CHOLINESTERASE BLOOD LEVEL; CHRONIC LIVER DISEASE; CHRONIC LIVER DISEASE QUESTIONNAIRE; DAILY LIFE ACTIVITY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; FEMALE; HUMAN; HYPOPROTEINEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; QUALITY OF LIFE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VIRUS HEPATITIS; FOLLOW UP; HEALTH STATUS INDICATOR; LIVER DISEASES; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

AGED; ASCITES; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84918788172     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12426     Document Type: Article

References (33)

1. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013: 58: 593.
2. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002: 36: 227.
3. Goldacre MJ. Demography of aging and the epidemiology of gastrointestinal disorders in the elderly. Best Pract Res Clin Gastroenterol 2009: 23: 793.
4. Pascher A, Nebrig M, Neuhaus P. Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis. Dtsch Arztebl Int 2013: 110: 167.
5. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007: 45: 797.
6. Tanikella R, Kawut SM, Brown RS Jr et al. Health-related quality of life and survival in liver transplant candidates. Liver Transpl 2010: 16: 238.
7. Saab S, Ibrahim AB, Shpaner A et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 2005: 11: 218.
8. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001: 96: 2199.
9. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997: 337: 473.
10. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006: 55(Suppl 6): vi1.
11. Stockmann M, Lock JF, Riecke B et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 2009: 250: 119.
12. Mizushima Y, Tohira H, Mizobata Y, Matsuoka T, Yokota J. Assessment of effective hepatic blood flow in critically ill patients by noninvasive pulse dye-densitometry. Surg Today 2003: 33: 101.
13. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999: 45: 295.
14. Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the Chronic Liver Disease Questionnaire. Eur J Gastroenterol Hepatol 2004: 16: 599.
15. Marchesini G, Bianchi G, Amodio P et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001: 120: 170.
16. Hauser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2004: 2: 157.
17. Sumskiene J, Sumskas L, Petrauskas D, Kupcinskas L. Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania. World J Gastroenterol 2006: 12: 7792.
18. Afendy A, Kallman JB, Stepanova M et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 2009: 30: 469.
19. Sola E, Watson H, Graupera I et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol 2012: 57: 1199.
20. Les I, Doval E, Flavia M et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol 2010: 22: 221.
21. Lampon N, Hermida-Cadahia EF, Riveiro A, Tutor JC. Association between butyrylcholinesterase activity and low-grade systemic inflammation. Ann Hepatol 2012: 11: 356.
22. Fuhrman MP. The albumin-nutrition connection: separating myth from fact. Nutrition 2002: 18: 199.
23. Ogunkeye OO, Roluga AI. Serum cholinesterase activity helps to distinguish between liver disease and non-liver disease aberration in liver function tests. Pathophysiology 2006: 13: 91.
24. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 2003: 6: 79.
25. Davis L, Britten JJ, Morgan M. Cholinesterase. Its significance in anaesthetic practice. Anaesthesia 1997: 52: 244.
26. Muller MJ. Malnutrition and hypermetabolism in patients with liver cirrhosis. Am J Clin Nutr 2007: 85: 1167.
27. Kondrup J. Nutrition in end stage liver disease. Best Pract Res Clin Gastroenterol 2006: 20: 547.
28. Alberino F, Gatta A, Amodio P et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001: 17: 445.
29. Tajika M, Kato M, Mohri H et al. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 2002: 18: 229.
30. Horsey PJ. The Cochrane 1998 Albumin Review-not all it was cracked up to be. Eur J Anaesthesiol 2002: 19: 701.
31. Montgomery RD. The relation of oedema to serum protein and pseudocholinesterase levels in the malnourished infant. Arch Dis Child 1963: 38: 343.
32. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006: 44: 217.
33. Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003: 48: 1622.